Blackstone buys Takeda’s consumer healthcare unit for $2.3 billion

For Takeda, the deal brings it close to its goal of $10 billion in asset disposals, as Japan’s largest drugmaker attempts to shed some of the $31 billion in debt that the Shire acquisition added to its balance sheet